Ocular Therapeutix (OCUL) Commences Enrollment in First OTX-TP Phase 3 in Glaucoma and Ocular Hypertension
Tweet Send to a Friend
Ocular Therapeutix, Inc. (Nasdaq: OCUL) announced the enrollment of the first patient in the first of two planned Phase 3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
